Thoracic Research and Practice
ORIGINAL INVESTIGATIONS

Plasma Leptin Concentrations in Patients with Stable Chronic Obstructive Pulmonary Disease

1.

Department of Chest Diseases, Fırat University Faculty of Medicine, Elazığ, Turkey

2.

Department of Biochemistry and Clinical Biochemistry,Firat University Faculty of Medicine, Elazığ, Turkey

3.

Department of Chest Disease, Fırat University, Faculty of Medicine, Elazığ, Turkey

Thorac Res Pract 2005; 6: Turkish Respiratory Journal 139-144
Read: 472 Downloads: 268 Published: 12 October 2021

Unexplained weight loss is common in patients with chronic obstructive pulmonary disease (COPD). Increased circulating of tumor necrosis factor-oc (TNF-oc) and leptin concentrations we­re reported in weight-losing COPD patients. Leptin is known to play important roles in the control of body-weight and energy expenditure. The aim of this study was to investigate circulating serum leptin and TNF-oc levels in patients with COPD, and to determine whether serum leptin levels are related to body mass index (BMI) or to TNF-oc levels. Serum concentrations of lep­tin, TNF-oc, albumin and creatinine clearance (CKr) were measu­red in 32 male patients with COPD and 18 healthy control sub­jects. Patients with COPD had significantly lower BMI, leptin, albumin and CKr levels than did the control subjects. Serum TNF-oc levels in COPD patients were significantly high compa­red to the healthy controls. Circulating leptin levels did not cor­relate with BMI and TNF-oc neither in COPD patients or in he­althy controls. These data suggest that circulating leptin is decreased and TNF-oc levels increased in patients with stable COPD. In addition, circula­ting leptin works independently of the TNF-oc system and does not primarily affect BMI in COPD patients.

Files
EISSN 2979-9139